Junctional epidermolysis bullosa of late onset explained by mutations in COL17A1.

Junctional epidermolysis bullosa of late onset explained by mutations in COL17A1.

Br J Dermatol. 2011 Jun;164(6):1280-4

Authors: Yuen WY, Pas HH, Sinke RJ, Jonkman MF

Abstract
BACKGROUND:   Junctional epidermolysis bullosa of late onset (JEB-lo) is a rare disease characterized by blistering of primarily the hands and feet starting in childhood. The pathogenesis remains unclear.
OBJECTIVES: To clarify the pathogenesis of JEB-lo.
METHODS: Two patients with JEB-lo, a brother and a sister, were examined using electron microscopy (EM), immunofluorescence (IF) antigen mapping and molecular analysis.
RESULTS: We found subtle changes in IF antigen mapping and EM. The most remarkable changes were loss of the apical-lateral staining of monoclonal antibodies (mAbs) against type XVII collagen (Col17), and a broadened distribution of mAb staining against the ectodomain of Col17, laminin-332 and type VII collagen. Mutation analysis of COL17A1, encoding Col17, showed a compound heterozygosity for a novel mutation c.1992_1995delGGGT and the known mutation c.3908G>A in both patients. The deletion c.1992_1995delGGGT results in a premature termination codon and mRNA decay, leaving the patients functionally hemizygous for the missense mutation c.3908G>A (p.R1303Q) in the noncollagenous 4 domain of Col17.
CONCLUSIONS: JEB-lo is an autosomal recessive disorder caused by mutations in COL17A1, and subtle aberrations in EM and IF antigen mapping are clues to diagnosis.

PMID: 21466533 [PubMed – in process]

This entry was posted in Br J Dermatol and tagged , . Bookmark the permalink.